Rheumatology
SARS-CoV-2 and myocardial injury: Few answers, many questionsWhat is the mechanism? Is this a distinct population? What are the treatment options?
- Polymyalgia rheumatica: An updated review
Suspect it in older patients with bilateral shoulder and hip stiffness in the morning.
- Cytokines and the still-baffling clinical biology of COVID-19
The primary culprit is not certain. Is it all immune damage, or is the continued persistence of coronavirus playing a role?
- Cytokine storm and the prospects for immunotherapy with COVID-19
Despite gaping holes in our knowledge, treatment is evolving.
- Perioperative infection: Are we sure what to focus on?
Which immunosuppressive drugs pose the greater danger in the perioperative period: the newer biologics or corticosteroids?
- Off-label and oft-prescribed
When prescribing drugs for uses beyond their FDA indications, we need to explain their anticipated side effects and benefits.
- Beyond depression: Other uses for tricyclic antidepressants
The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.
- A link between A-fib and sleep apnea is no surprise, but why?
The two conditions commonly coexist, and treating the sleep apnea results in better rhythm-directed outcomes in the A-fib.
Appropriate laboratory testing in Lyme diseaseTesting for Lyme disease is challenging and if done incorrectly can lead to unnecessary treatment.